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Abstract 
 
Background  
With the fast evolution of high-throughput technology, longitudinal gene expression experiments have 
become affordable and increasingly common in biomedical fields. Generalized estimating equation 
(GEE) approach is a widely used statistical method for the analysis of longitudinal data. Feature 
selection is imperative in longitudinal omics data analysis. Among a variety of existing feature selection 
methods, an embedded method — threshold gradient descent regularization (TGDR) stands out due to 
its excellent characteristics. An alignment of GEE with TGDR is a promising area for the purpose of 
identifying relevant markers that can explain the dynamic changes of outcomes across time.  
Methods 
We proposed a new novel feature selection algorithm for longitudinal outcomes— GEE-TGDR. In the 
GEE-TGDR method, the corresponding quasi-likelihood function of a GEE model is the objective 
function to be optimized and the optimization and feature selection are accomplished by the TGDR 
method.   
Results  
We applied the GEE-TGDR method a longitudinal lncRNA gene expression dataset that examined the 
treatment response of psoriasis patients to immune therapy. Under different working correlation 
structures, a list including 10 relevant lncRNAs were identified with a predictive accuracy of 80 % and 
meaningful biological interpretation.  
Conclusions 
A widespread application of the proposed GEE-TGDR method in omics data analysis is anticipated.  
 
Keywords: Feature selection; generalized estimating equation (GEE); threshold gradient descent 
regularization (TGDR); long non-coding RNA (lncRNA); longitudinal; psoriasis.  
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Background  
With fast evolution of high-throughput technology, longitudinal omics experiments have become 
affordable and increasingly common in many biomedical fields for exploring dynamically or temporally 
changed biological systems or processes. Usually, the analysis strategies focus on analyzing individual 
time points separately. As many investigators have pointed out [1–4], a failure to incorporate 
information contained in the dependent structure of time course data results in inefficient estimation of 
the standard errors, leading to an inadequate statistical power. Especially in big omics studies, this 
problem stands out since the sample size of such data is usually small. Furthermore, an over-simplified 
consideration by combining the results from marginal analysis at individual time points tends to fail to 
detect a meaningful pattern of changes over time.  
 
The generalized estimating equation (GEE) approach [5] is a well-established and widely used statistical 
method to analyze longitudinal data. GEE considers the first two marginal moments (i.e., mean and 
variance) of data and a working correlation matrix to model correlated responses, artfully avoiding the 
specification of full joint likelihood function. The appeal of GEE lies in that it yields consistent 
estimators for the parameters of interest, even if the working correlation structure is incorrectly specified. 
Naturally, GEE has been modified or extended to identify differentially expressed genes over time for 
high-throughput data. Such modifications and/or extensions are not simple due to the high 
dimensionality of omics data, although some efforts have been made [1, 2, 6].  
 
Like its cross-sectional counterpart, feature selection is imperative in the learning process for 
longitudinal omics data. Feature selection aims at eliminating irrelevant genes, avoiding over-fitting, 
speeding up the learning process and achieving a final model that is parsimonious (i.e., the number of 
selected genes is as least as possible). Consequently, a modification to GEE to analyze high-dimensional 
data necessitates the involvement of feature selection. In the literature, there are several such algorithms. 
For example, Wang et al [2] used an smoothly clipped absolute deviation (SCAD) penalty term [7] 
which is a novel extension to the L1 penalty to equip the GEE models with feature selection capacity. 
The L1 penalty, also known as LASSO [8], force genes with small estimated coefficients out of the final 
model, rendering a sparse solution by the means of which feature selection occurs. However, two 
subsequent works on this topic [1, 6] showed that this algorithm usually fails to converge when the 
number of covariates is much larger than the number of samples. This drawback is more apparent and 
fatal in longitudinal omics data, where the sample size is typically smaller than that of a cross-sectional 
study.    
 
Among a variety of existent feature selection algorithms, we have devoted dramatic efforts on the 
threshold gradient descent regularization (TGDR) [9] method (see the Methods section for its 
description). Previously, we had extended TGDR for classification task of multiple groups (>2) and for 
identification of subgroup-specific prognostic genes with a survival outcome [10–14]. By applying these 
TGDR extensions to different types of omics data including microarray, RNA-Seq and mass 
spectrometry (MS) data, we have shown that TGDR and its respective extensions have many merits 
including easy-to-moderate programming intensity, good predictive performance and biologically 
meaningful implications of the resulting signatures. In a recent work [4], we show that the TGDR 
algorithm can be regarded as an optimization strategy, and that the final models given by TGDR have 
superior predictive performance and more meaningful biological interpretation than the LASSO  models 
optimized by the coordinate descent method [15]. Therefore, we think an integration of GEE with 
TGDR may overcome the drawbacks of existing approaches for the purpose of longitudinal feature 
selection. 
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Long non-coding RNAs (lncRNAs) are post-transcriptional and epigenetic regulators, and have the 
characteristics of lower expression levels and more tissue-specific compared with protein-coding genes 
[16]. Once being regarded as evolutionary junks, lncRNAs have been demonstrated to play essential 
roles in many complex diseases, especially in cancers [16].  
 
 
In this article, we proposed a new feature selection algorithm, referred to as GEE-TGDR, specifically for 
longitudinal data mining and feature selection. In the GEE-TGDR method, the corresponding quasi-
likelihood function of a GEE model is the objective function to be optimized, while the optimization and 
feature selection are accomplished by the TGDR method. We applied this method to a longitudinal 
microarray gene expression data that aims at assessing the treatment efficacy of two immune therapies 
for psoriasis patients, and identified the relevant lncRNAs that can predict the temporal changes of 
psoriasis area and severity index (PASI) scores that is utilized to determine if a patient with psoriasis 
responds to the treatments, with the objectives of revealing the underlying mechanisms of these two 
treatments from the perspective of lncRNAs.  
 
As pointed out by our previous study [17], psoriasis is an ideal model for examining the effects of 
targeted immune treatments given that it is well characterized by molecular profiles, displays low 
placebo effects and possesses easily accessible diseased tissues. So far, the implication of lncRNAs in 
psoriasis remains largely unexplored and poorly understood. Among the limited research carried out to 
explore the roles of lncRNAs play in psoriasis, however, some encouraging results have turned up. For 
example, a very recent study [18] has shown that antisense non coding RNA in the INK4 locus (ANRIL) 
can be regarded as a risk locus of psoriasis. Therefore, the roles of lncRNAs play in psoriasis deserve to 
be explore deeply and widely.  
 
 
Materials and Methods 
Experimental Data  
The microarray dataset [17] used in this study to validate the proposed GEE-TGDR algorithm was in the 
Gene Expression Omnibus (GEO) database (https://www.ncbi.nlm.nih.gov/geo/) under the accession 
number of  GSE85034. There were 179 arrays in this experiment, including the gene expression profiles 
of 30 patients with moderate to severe psoriasis at the baseline non-lesion skins, baseline lesion skins, 
and weeks 1, 2, 4 and 16. Of the 30 patients, half were administrated with adalimumab (ADA) and the 
other half were treated with methotrexate (MTX). Of note, one patient on the ADA arm had no 
expression measurements of week 16 since his/her psoriasis area and severity index (PASI) score 
already had experienced a 75 % decrement at the week 4. In original paper, a treatment response was 
based on a reduction of 75 % in PASI score after week 12 or later. Longitudinal profiles of PASI scores 
(at baseline lesion skins, weeks 1, 2 and 4) were the outcomes of interest, and the lncRNA expression 
values of the baseline lesional skins serve as potential predictors to investigate if they are relevant to the 
PASI scores of psoriasis patients over time.   
 
In this study, the pre-processed data were directly downloaded from the GEO database. No alternative 
pre-processing had been carried out. By matching the gene symbols of lncRNAs in the GENCODE 
(https://www.gencodegenes.org/) database (version 32) to those of genes annotated by the Illumina 
HumanHT-12 V 4.0 bead chips, 662 unique IncRNAs were identified and included in the downstream 
analysis. 
 
Statistical Methods  
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In this paper, we conceive a new novel feature selection algorithm called GEE-TGDR specifically for 
selecting relevant features associated with the temporal changes of longitudinal outcomes, in which GEE 
is equipped with TGDR just as its name implies. We briefly described both GEE and TGDR methods 
before proceeding to the proposed integration. Here, to keep it the most relevant, we focused on the case 
of continuous outcomes.  
 
TGDR  
For continuous outcomes, the TGDR algorithm is based on a linear model, where a response variable Yi 
(i=1,…, n, n is the sample size) is modelled by a P-dimensional vector of observed covariates Xip (here, 
p =1, ..., P) as E(Y)=XTβ. Here, β’s represents the coefficients of covariates for the magnitudes of 
association between covariates and the outcome. For continuous outcomes, a normal distribution is 
usually assumed and then the corresponding likelihood function is used as a response function/an 
objective function in the TGDR algorithm. With some algebraic simplification, the response function 
can be written as,  
𝑅𝑒𝑠 𝛽 = 𝑛'( 𝑌* − 𝑋*-𝛽 ./*0(  
The TDGR algorithm started from that the βs were initially set at zero’s (corresponding to the null 
model).  Using Δv to denote a small positive increment (e.g., 0.01) in the gradient descent search and 
vk=k×Δv to be the index for the point along parameter path for iteration k, 
1.   Upon current estimate β(vk), a negative gradient matrix g with its pth component as gp(vk) are 
calculated as, 
−𝜕𝑅𝑒𝑠 𝛽 𝑣3𝜕𝛽4 = 𝑔4(𝑣3) = 𝑛'( 𝑥*4(𝑦* − 𝑥*-𝛽(𝑣3))/*0(  
2.   Let f(vk) represent the threshold vector of size p at iteration k, then its pth component (for the pth 
gene) is,  𝑓4 𝑣3 = 𝐼(|𝑔4(𝑣3)| ≥ 𝜏×max	  (|𝑔D 𝑣3D∈F |))	   
3.   Update βp(vk+1) = βjp(vk) - Δv×gp(vk) ×fp(vk)  and vk+1=vk+Δv.  
 
4.   Repeat steps 1-3 for K times. K can be regarded as a tuning parameter, with a large value 
corresponding to a dense model (more non-zero coefficients) and a small value to a sparse model (less 
non-zero coefficients). The optimal value of K is determined by cross-validations (CVs).  
In the TGDR method, no explicit penalty term is added to the objective function (i.e., response 
function). The regularization on coefficients (thus the selection of features) is made possible by 
introducing the threshold function f(vk) in step 2, which determines if the gradient of a coefficient is 
large enough to descent or more precisely speaking to be updated. For more detailed description of the 
TGDR method, the works [9, 19] are referred.  
 
 6 
GEE  
In the longitudinal notation, the jth time point/measurement of the ith subject, a t-dimensional vector of 
response variables Yij (here, i =1, ..., n and j =1, ..., t) and a P-dimensional vector of covariates Xip (here, 
p =1, ..., P) are observed. Thus Yi. = (Yi1,...,Yit )T denotes the vector of responses at t different time points 
for subject i and Xi =(Xi1,...,XiP)T is P covariates for subject i. For the purpose of a simplified notation, t 
is assumed to be the same for each individual.  
In the GEE model, the first two marginal moments of Yij are denoted by µij(β)=E(Yij) (the expectation of 
Y) and σ2(β) = V(Yij) (the variance of Y). Here, β’s are the coefficients representing the magnitude of 
association between covariates and outcomes, with βjp representing how attribute p is associated with the 
value of outcome Y.j (meaning the outcome at time point j). Those β’s are parameters of interest. 
Furthermore, the distribution of Yij is assumed to belong to an exponential family with a canonical link 
function. Let µi(β) = (µi1(β1),..., µit(βt))T and Ai(β)= diag(σ2i1(β1),...,σ2it(βt)), then under a canonical link 
function Vi(β)=Ai1/2(β)Ri(α)Ai1/2(β). Here, Ri(α) is an t×t working correlation matrix with α as the finite 
dimensional parameter vector for correlations, which would be usually estimated by the residual-based 
moment method. In a GEE model, the quasi-likelihood function can be written as,   
𝑄𝐿 𝛽 = 𝑛'( 𝑌*. − 𝜇* 𝛽 𝑉*'( 𝛽/*0( (𝑌*. − 𝜇* 𝛽 ) 
Four structures are commonly used for the working correlation matrix Ri(α) — first-order autoregressive 
(AR1), exchangeable, unstructured and independent structure.  
GEE-TGDR  
The conventional TGDR method only deals with univariate outcomes. As far as longitudinal outcomes 
that are multivariate are concerned, the method needs to be extended.  
Here, we proposed to replace a likelihood function with a quasi-likelihood function and to extend TGDR 
as GEE-TGDR. With Δv denoting a small positive increment (e.g., 0.01) in gradient descent search and 
vk=k×Δv being the index for the point along parameter path after k steps, the GEE-TGDR algorithm is 
iterated in the following steps until the stopping criteria are met, 
1.   Upon current estimate β(vk), a negative gradient matrix g with its (j,p)th component as gjp(vk) are 
calculated, 
−𝜕𝑄𝐿 𝛽 𝑣3𝜕𝛽L4 = 𝑔*4(𝑣3) = 𝑛'( 𝑋L4-/*0( 𝐴*(.(𝛽(𝑣3))𝑅'((𝛼)𝐴*'(.(𝛽(𝑣3))(𝑌*. − 𝜇*(𝛽(𝑣3))) 
2.   Let fj(vk) represent the threshold vector of size p for the jth time point (j=1,..,t) at step k, then its 
pth component (for the pth gene) is,  𝑓L4 𝑣3 = 𝐼(|𝑔L4(𝑣3)| ≥ 𝜏×max	  (|𝑔LD 𝑣3D∈FO |))	  ∀𝑗 ∈ 𝛽L 
3.   Update βjp(vk+1) = βjp(vk) - Δv×gjp(vk) ×fjp(vk)  and vk+1 to vk+Δv.   
 
 7 
4.   Calculate the residuals Yi-µi(β(vk)), and based on them, to estimate the nuisance parameters 
involved in R(α) (for different correlation structures, the parameters are different) and A(β(vk)).  Of 
note, since at different time points we have different threshold function, the selected genes at different 
time points are expected to differ. In this way, the selection of critical time points is possible.   
 
5.   Repeat steps 1-4 for K times. K is a tuning parameter, the same as in the conventional TGDR 
method. The optimal value of K is also determined by CVs.  
In this study, we only developed the GEE-TGDR algorithm for continuous outcomes (given in the 
motivated database, PASI scores which are continuous were the outcomes of interest), thenthe 
corresponding expectations of Y’s are,  
𝐸 𝑌*(⋮𝑌*T = 𝛽(U + 𝛽((𝑥*( + ⋯+ 𝛽(4𝑥*4⋮𝛽TU + 𝛽T(𝑥*( + ⋯+ 𝛽T4𝑥*4  
 
Since the outcomes were continuous, the mean squared error (MSE) statistic was calculated to evaluate 
the performance of resulting gene signatures. It is worth pointing out that for the outcomes of other 
types, an extension suitable for the underlying data type of GEE-TGDR algorithm is straightforward, 
with the corresponding quasi-likelihood function serving as the objective function/response function.  
 
Statistical Language and Packages 
Statistical analysis was carried out in the R language version 3.6.1 (www.r-project.org). 
 
Results   
In this study, we propose to extend the feature selection algorithm TDGR to account for correlation 
structure of longitudinal data. This is accomplished by defining the objective function of TDGR as the 
corresponding quasi-likelihood function, which as in GEE is specified based on the first two moments 
and a working correlation matrix. TDGR-GEE is described in the Materials and Methods section. In this 
section, we illustrate the application of the proposed method while looking for biomarkers that predict 
clinical resolution of psoriasis after being treated with two immune therapies. 
 
Gene expression profiles of baseline lesional skin biopsies were obtained for 30 subjects followed up to 
16 weeks after treatment with adalimumab and methotrexate. Clinical resolution at week 1, 2 and 4 was 
measured by PASI. In this example we would like to identify a signature of genes whose baseline 
expression valuess correlate with changes in PASI, our continuous longitudinal outcome. WE used 662 
lnRNA as covariates in the proposed GEE-TGDR model, under 4 different working correlation 
structures. The performance statistics and identified lncRNA genes are presented in Table 1 
 
In this example, the results obtained under working correlation structures exchangeable, unstructured 
and independent barely differ, with with similar set of biomarkers leading to similar performance. This 
reflects a well known robust characteristics of GEE, where when predictors are correctly given, the GEE 
estimates remain consistent even if the correlation structures is misspecified.  Under the AR1 structure, 
GEE-TGDR identified only one lncRNA as being related to PASI scores, leading to an under-fitting and 
inferior to the performance when compared to the other three correlation structures. 
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Due to the patient burden and budgetary restrictions, longitudinal omics data are usually very short and 
unevenly spaced. In this case, AR1 is not well suited and the unstructured correlation may be the most 
suitable structure, even though that this structure corresponds to a model with more nuisance parameters 
involved in the corresponding working correlation structure. 
 
Cross-validation results gave us an idea for the variability in the model performance in this regard, CV 
results indicated that all correlation structures but AR1 structure provided similar results, with both the 
exchangeable and independent structures having the least MSEs but a bigger variability and the 
unstructured structure having a larger MSE but the smaller variations. 
 
Even though that at individual time points the identified features varied substantially for the 
unstructured, exchangeable and independent working correlation structures (Figure1), the unions of 
lncRNA lists across time are essentially the same, including 9 lncRNAs identified by all these three 
structures and one lncRNA selected by the independent structure alone (Figure 2).  
 
In order to gain biological insight identified biomarkers, we evaluated the relevance to psoriasis of the 
10 identified lncRNA using disease confidence scores, where a high score represents a solid support by 
the literature according to the GeneCards database.  None of the 10 lncRNAs were directly related to 
psoriasis while 5 lncRNAs, listed in a descending order for the confidence scores, and thus descending 
support by the literature according to the GeneCards database, MIR205, XIST, SNHG5, LINC01139 and 
SDHAP2 were associated with immunity. Here, little meaningful information was extracted from 
currently annotated lncRNA databases, no surprisingly since that psoriasis remains largely unexplored 
from the perspective of lncRNAs. We thus focused on studying the mRNAs correlated or targeted by 
these lncRNAs. Specifically, we identified the genes whose baseline lesional expression was strongly 
correlated with at least one of the 10 lnRNA (|Spearman correlation coefficient|>0.6, FDR< 0.001) and 
identified 225 mRNAs genes. According to the GeneCards database[20], approximately 30 % of these 
mRNAs (64) were directly related to psoriasis, most notably IL10, FABP5, KRT16, CCR6, IL18, STAT3, 
GATA3 and SERPINB3, providing some validation of the lncRNA biomarkers identified by the GEE-
TGDR method. In contrast, among the 29 target mRNAs identified by the lncRNA Disease 2.0 database 
[21] as targeted by the 10 lnRNA panel [all of which were identified by the correlation approach), 
GeneCards claimed that CCR10, AOC3, UBB and WNK4 were directly related to psoriasis, but only 
CCR10 had a large confidence score for its relevancy to psoriasis. Of note, among the 10 lncRNAs only 
RAMP2-AS1, PAX1P1-AS1, TMEM99 and LIN01018 have many correlated mRNAs, but the others five 
have few or no correlated mRNAs at all. 
 
We conducted a gene-set overrepresentation analysis for the 225 mRNAs identified as targeted by the 10 
lnRNA biomarker panel using the STRING software [22] on KEGG and GO collections.  About 346 
enriched biological process (BP) terms, 23 molecular function (MF) terms and 21 cellular component 
(CC) terms were identified in the GO collection reflecting the immune pathophysiology of the disease. 
The top 3 enriched KEGG pathways [23] reflected the inflammatory processes identifying inflammatory 
bowel diseases (FDR=0.0006) and  Cytokine-cytokine receptor interaction (FDR=0.0051) but also 
zeroing on the hallmark pathway in psoriasis: Th17 differentiation (FDR=0.0313). 
 
Lastly, among the 225 mRNA, we selected the top 10 in terms of psoriasis-relevance (confidence score 
for relevancy >15) and constructed a lncRNA-mRNA interaction network, visualized by Cytoscape 
software [24] (Figure 4).  We observed that the target mRNAs are highly connected, with IL10 serving 
as a hub gene. It is well-known that IL10 is an immunosuppressive cytokine and enables to maintain 
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immunological homeostasis [25]. Based on this, we anticipate that identified lncRNAs may regulate the 
expression of important cytokines such as IL10 and warrant further investigation.    
 
Discussion  
The GEE-TGDR method has several limitations. First, no grouping structure is taken into account and 
thus the GEE-TGDR method belongs to the conventional embedded feature selection category. So far, 
accumulated studies [26–29] have shown that a pathway-based method that considers grouping 
information is superior to its gene-based counterpart in which grouping information is ignored. Thus, 
how to extend the proposed GEE-TGDR method to account for correlations among genes is a research 
avenue we will pursue in the near future.  
 
Second, the TGDR method is much slower than the coordinate descent (CD) [15] method as shown by 
our previous study [4]  Given that the GEE-TGDR extension has the TGDR method as an optimization 
strategy, its speed of convergence is expected to be very slow. A method that combines the merits of 
these two algorithms together is definitely in demand. 
 
Third, the GEE-TGDR method only takes time-invariant covariates in its current version. For 
longitudinal gene expression profiles, a summary score would be utilized to summarize each gene’s 
gene expression values over time as one overall value. Consequently, covariates became time-constant 
again. For example, the mean values of lncRNA expression profiles at baseline and week 1 can be used 
to represent the corresponding lncRNAs and then as the covariates to investigate they are associated 
with PASI scores at week 1, week 2 and week 4 or the change of PASI scores at those time points from 
the baseline levels. On the other hand, the GEE-TGDR method can be certainly extended to handle time-
varying covariates, which can examine the impact of dynamic changes in gene expression values on the 
outcomes of interest and thus facilitate a timely adjustment on treatment strategies accordingly.  
 
Lastly, right now the only type of outcomes is continuous, yet certainly it can be extended to handle 
outcomes of other types, with the corresponding quasi-likelihood function acting as the objective 
function. Right now, over-fitting might be possible on the basis of the large discrepancy in MSE 
statistics between the whole training set and the cross-validations. Even worse but more realistic, over-
fitting and under-fitting may accompany each other to exist in a feature selection process. Since for the 
real-world applications, the true relevant genes are unknown so the biological relevance is usually 
resorted to abstract some insight about the appropriation of identified gene lists. Nevertheless, for 
psoriasis and the underlying mechanism of immune treatments to combat this disease, little has been 
investigated from the perspective of lncRNAs to mine such relevant information. To the best of our 
knowledge, our work here is one of first efforts to unveil the mechanisms of psoriasis and its immune 
treatments using longitudinal lncRNA expression profiles and a feature selection method specific for 
such data.  
 
With future work to eliminate these limitations, we believe that an lncRNA signature will be harvested 
to tell precisely which patients would respond to an immune treatment from those who would not, and 
thus facilitating personalized regimens or at least complementing other molecular markers for precise 
treatment strategies.  
 
Conclusions    
Besides dealing with longitudinal clinical outcomes, the GEE-TGDR can be adopted to inference the 
associations between lncRNAs and mRNAs and thus construct lncRNA-mRNA interaction networks. 
For example, using well-known cancer-related mRNAs as outcomes, the lncRNAs that may potentially 
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regulate/target those mRNAs could be found with the aid of the GEE-TGDR method. Therefore, we 
anticipate a widespread application of the proposed method in omics data analysis.  
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Table 1. Results of psoriasis lncRNA longitudinal data (using baseline expression values only as 
predictors)   
 
 Ave. of MSE  SD of  
MSE 
MSE  Identified lncRNAs (using all data)  
 (5-fold CVs) (CVs)  (all data) Baseline  Week 1 Week 2 Week 4 
AR1 14.456 3.258 2.101 RAMP2-AS1 RAMP2-AS1 RAMP2-AS1 RAMP2-AS1 
Unstructured  3.725 0.498 0.793 XIST      
RAMP2-AS1 
MIR205 
LRRC75A-AS1 
PAXIP1-AS1  
LINC00667   
RAMP2-AS1   
MIR205 
LRRC75A-AS1 
TMEM99      
LINC01018   
PAXIP1-AS1 
LINC01139   
RAMP2-AS1 
TMEM99 
LINC01018  
PAXIP1-AS1 
LINC01139  
RAMP2-AS1 
Exchangeable  2.758 1.649 0.767 XIST      
RAMP2-AS1 
MIR205 
LRRC75A-AS1 
XIST        
LINC01139   
SDHAP2      
RAMP2-AS1 
TMEM99    
LINC01139 
RAMP2-AS1 
TMEM99     
XIST       
LINC01018 
PAXIP1-AS1 
LINC01139  
RAMP2-AS1 
Independent  2.675 1.694 0.760 SNHG5     
LINC01139 
RAMP2-AS1 
MIR205   
SNHG5     
RAMP2-AS1 
MIR205 
SNHG5    
TMEM99   
RAMP2-AS1 
MIR205 
SNHG5      
XIST      
LINC01018 
LINC01139 
RAMP2-AS1 
MIR205 
AR1: autoregressive order 1; MSE: mean squared error; SD: standard deviation; CV: cross-validation.  
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Figures 
 
Figure 1. Venn-diagram of identified lncRNAs for baseline, weeks 1, 2 and 4 respectively by 
different working correlation structures. A) Under the unstructured working correlation structure. B) 
The exchangeable working structure. C) The independent working structure.  
 
 
 
 
Figure 2. Venn-diagram of integrated lncRNAs by three working correlation structures. 
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Figure 3. Temporal trajectories of the identified 10 lncRNAs showing that all lncRNAs exhibited 
going back to normal level patterns. 
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Figure 4. Resulting interaction network of identified lncRNAs and their correlated mRNAs. Here, 
only mRNAs with high enough confidence scores for the relevancy to psoriasis were considered. From 
the network, it is observed that IL10 is a hub gene directly connecting several other mRNAs and three 
identified lncRNAs.  Four lncRNAs were highlighted in yellow, and the other six lncRNAs without 
correlated mRNAs were omitted from the graph.    
 
 
 
  
 
 
